GC
GC Cell
Yongin KRFounded 2017200 employees
Private CapbiotechPrivateOncology
Platform: NK Cell Ther
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GC-6461 | GC-6461 | Preclinical | 2 | CDK4/6 | CML | ||
| GC-7403 | GC-7403 | Phase 2/3 | 2 | PI3Kα | ObesityGA | ||
| Ivorasimod | GC-3526 | Approved | 3 | PD-1 | CKDPompe |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)